213 related articles for article (PubMed ID: 30745461)
1. Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in Mice.
Shen F; Verma AH; Volk A; Jones B; Coleman BM; Loza MJ; Malaviya R; Moore B; Weinstock D; Elloso MM; Gaffen SL; Ort T
J Immunol; 2019 Apr; 202(7):2017-2026. PubMed ID: 30745461
[TBL] [Abstract][Full Text] [Related]
2. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
[TBL] [Abstract][Full Text] [Related]
3. Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance.
Zwerina K; Koenders M; Hueber A; Marijnissen RJ; Baum W; Heiland GR; Zaiss M; McLnnes I; Joosten L; van den Berg W; Zwerina J; Schett G
Eur J Immunol; 2012 Feb; 42(2):413-23. PubMed ID: 22101928
[TBL] [Abstract][Full Text] [Related]
4. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis.
Yamaguchi Y; Fujio K; Shoda H; Okamoto A; Tsuno NH; Takahashi K; Yamamoto K
J Immunol; 2007 Nov; 179(10):7128-36. PubMed ID: 17982105
[TBL] [Abstract][Full Text] [Related]
5. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
6. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases.
Silacci M; Lembke W; Woods R; Attinger-Toller I; Baenziger-Tobler N; Batey S; Santimaria R; von der Bey U; Koenig-Friedrich S; Zha W; Schlereth B; Locher M; Bertschinger J; Grabulovski D
MAbs; 2016; 8(1):141-9. PubMed ID: 26390837
[TBL] [Abstract][Full Text] [Related]
9. cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing T
Kawalkowska JZ; Ogbechi J; Venables PJ; Williams RO
Sci Adv; 2019 May; 5(5):eaaw5422. PubMed ID: 31049403
[TBL] [Abstract][Full Text] [Related]
10. A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor α.
Liu Z; Song L; Wang Y; Xu P; Guo X; Yang J; Liu H; Wang Y; Wu C; Zhang T; Yu D; Opoku YK; Khoso MH; Ren G; Li D
Int J Pharm; 2018 Aug; 547(1-2):72-82. PubMed ID: 29803792
[TBL] [Abstract][Full Text] [Related]
11. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
[TBL] [Abstract][Full Text] [Related]
13. Dual Blockade of Interleukin-1
Ruzek MC; Huang L; Zhang TT; Bryant S; Slivka PF; Cuff CA; Tripp C; Blaich G
J Pharmacol Exp Ther; 2018 Mar; 364(3):474-484. PubMed ID: 29311111
[TBL] [Abstract][Full Text] [Related]
14. Considerations with the use of biological therapy in the treatment of rheumatoid arthritis.
Fleischmann RM; Iqbal I; Stern RL
Expert Opin Drug Saf; 2004 Sep; 3(5):391-403. PubMed ID: 15335295
[TBL] [Abstract][Full Text] [Related]
15. Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A.
Zheng S; Shen F; Jones B; Fink D; Geist B; Nnane I; Zhou Z; Hall J; Malaviya R; Ort T; Wang W
MAbs; 2020; 12(1):1770018. PubMed ID: 32544369
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
[TBL] [Abstract][Full Text] [Related]
17. Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis.
Hammoura I; Fiechter RH; Bryant SH; Westmoreland S; Kingsbury G; Waegell W; Tas SW; Baeten DL; van de Sande MGH; van Tok MN; van Duivenvoorde LM
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055042
[TBL] [Abstract][Full Text] [Related]
18. STAT6 and IL-10 are required for the anti-arthritic effects of Schistosoma mansoni via different mechanisms.
Osada Y; Horie Y; Nakae S; Sudo K; Kanazawa T
Clin Exp Immunol; 2019 Jan; 195(1):109-120. PubMed ID: 30194773
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.
Zrioual S; Ecochard R; Tournadre A; Lenief V; Cazalis MA; Miossec P
J Immunol; 2009 Mar; 182(5):3112-20. PubMed ID: 19234208
[TBL] [Abstract][Full Text] [Related]
20. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
